FilingsTodayYoungbo Chemical
At a glance
Youngbo Chemical filed 15 disclosures in the last 12 months.
Revenue for 2025 was ₩120B, up 2.2% on 2024. Operating margin was 16.1% against 16.5% a year earlier. Debt was 10% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩60.2B and operating profit of ₩8.2B.
The 2025 annual report lists 234 employees with an average tenure of 19.2 years and average pay of ₩98.9M, #170 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩82.2M each on average. It paid ₩350 per common share in cash dividends, against ₩350 a year earlier (+0%). 적수화학공업(주) and related parties held 51.00% at year end.
From the 2025 annual report
Staff: 234 (225 men, 9 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩23.2B. Directors and auditors: 6, paid ₩492.9M in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩350 | ₩350 | ₩50 |
| Payout ratio | 40.5% | 30.3% | 16.4% |
| Yield (as filed) | 6.59% | 9.71% | 1.36% |
| Total cash dividends | ₩6.8B | ₩6.8B | ₩975M |
Largest shareholder
적수화학공업(주) holds 51.00%; with 0 related parties the group holds 51.00% of common shares at year end.
Auditor: 삼정회계법인 · opinion: Unqualified.
Rankings: Tenure #13 of 1,841 · Low debt #31 of 1,372 · Dividend yield #57 of 1,084
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
No key filings in the last 12 months.
Other filings
Links open the original filing on DART, in Korean.